Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS)
CNY 12.41
(-4.98%)
CNY 12.41
(-4.98%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.27 CNY | 28.57% |
| 2022 | 0.21 CNY | 16.67% |
| 2021 | 0.18 CNY | -40.0% |
| 2020 | 0.30 CNY | 0.0% |
| 2019 | 0.30 CNY | -3.23% |
| 2018 | 0.31 CNY | 138.46% |
| 2017 | 0.13 CNY | -76.79% |
| 2016 | 0.56 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.07 CNY | -14.53% |
| 2024 Q2 | 0.12 CNY | 71.43% |
| 2024 Q3 | 0.01 CNY | -89.33% |
| 2023 FY | - CNY | 28.57% |
| 2023 Q1 | 0.10 CNY | 189.86% |
| 2023 Q2 | 0.05 CNY | -48.0% |
| 2023 Q3 | 0.04 CNY | -22.5% |
| 2023 Q4 | 0.08 CNY | 103.23% |
| 2022 Q4 | 0.03 CNY | 3.29% |
| 2022 Q1 | 0.07 CNY | 610.95% |
| 2022 Q3 | 0.03 CNY | -48.46% |
| 2022 Q2 | 0.06 CNY | -7.43% |
| 2022 FY | - CNY | 16.67% |
| 2021 Q3 | 0.06 CNY | -9.8% |
| 2021 Q1 | 0.06 CNY | -50.0% |
| 2021 FY | - CNY | -40.0% |
| 2021 Q4 | -0.01 CNY | -121.27% |
| 2021 Q2 | 0.07 CNY | 19.0% |
| 2020 Q3 | 0.08 CNY | 8.39% |
| 2020 Q4 | 0.12 CNY | 47.42% |
| 2020 FY | - CNY | 0.0% |
| 2020 Q1 | 0.05 CNY | -76.19% |
| 2020 Q2 | 0.08 CNY | 50.2% |
| 2019 Q1 | 0.05 CNY | 0.0% |
| 2019 FY | - CNY | -3.23% |
| 2019 Q2 | 0.07 CNY | 40.8% |
| 2019 Q4 | 0.21 CNY | 1029.03% |
| 2019 Q3 | 0.02 CNY | -73.58% |
| 2018 FY | - CNY | 138.46% |
| 2017 FY | - CNY | -76.79% |
| 2016 FY | - CNY | 0.0% |